Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma
Open accessThe DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
PURPOSE: This study endeavors to build a deep learning (DL)-based model for predicting disease progression in head and neck squamous cell carcinoma (HNSCC) patients by integrating multi-omics data. METHODS: RNA sequencing, miRNA sequencing, and methylation data from The Cancer Genome Atlas (TCGA) were used as input for autoencoder, a DL approach. An autoencoder-based prognosis model for PFS was built by SVM algorithm and tested in three confirmation sets. Predictive performance of the model was compared to two alternative approaches. Differential expression analysis for mRNAs, microRNAs (miRNA) and methylation was conducted. Moreover, functional annotation of differentially expressed genes (DEGs) was achieved through function enrichment analysis. RESULT: The DL-based prognosis model identified two subgroups of patients with significantly different PFS, and showcased a good model fitness (C-index = 0.73). The two identified PFS subtypes were successfully validated in three confirmation sets. The DL-based model was more accurate and efficient than principal component analysis (PCA) or individual Cox-PH-based models. There were 348 DEGs, 23 differentially expressed miRNAs and 55 differentially methylated genes between the two PFS subtypes. These genes were significantly involved in several immune-related biological processes and primary immunodeficiency, cell adhesion molecules (CAMs), B cell receptor signaling and leukocyte transendothelial migration pathways. CONCLUSION: The DL-based model introduced in this study is reliable and robust in predicting disease progression in HNSCC patients. A number of pathways and genes targets are unraveled to be implicated in cancer progression. Utility of this model would facilitate development of more individualized therapy for HNSCC patients and improve prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Particularly in cancer patient survival subtyping with multi-omics modalities, this sequence of steps has become popular [25–31, 34].”
From Multimodal deep learning for biomedical data fusion: a review (2022) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“Differential expression analysis for the mRNAs, miRNAs expression and methylation genes was carried out between the two PFS subtypes by DESeq2 package [23] (http://www.bioconductor.org/packages/relea se/bioc/html/DESeq2.html).”
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850 · cited 1×
“Head and neck squamous cell carcinoma (HNSCC) accounts for more than 90% of all head and neck cancers, and is one of the most common cancers world-1 wide with over 500,000 new cases annually [1,2].”
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392 · cited 1×
“Silhouette index [14] and Calinski-Harabasz criterion [15] were used to decide the optimal number of clusters.”
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602252 · Cited by 5,101 · cited 1×
“Recurrence is reported in over 50% of patients within three years after diagnosis [4,5].”
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Xie, C., Mao, X., Huang, J., Ding, Y., Wu, J., Dong, S., Kong, L., Gao, G., Li, C.-Y., & Wei, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr483 · Cited by 5,094 · cited 1×
“Gene ontology (GO) function and pathway enrichment analyses were carried out with the python goa-tools package [25] and kobas 3.0 interface [26], respectively.”
InfluentialA dendrite method for cluster analysis
Caliński, T., & Harabasz, J. (1974) · Communications in Statistics · doi:10.1080/03610927408827101 · Cited by 4,480 · cited 1×
“Silhouette index [14] and Calinski-Harabasz criterion [15] were used to decide the optimal number of clusters.”
Pignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069
Lee, H., Grosse, R., Ranganath, R., & Ng, A. Y. (2009) · Proceedings of the 26th Annual International Conference on Machine Learning · doi:10.1145/1553374.1553453 · Cited by 2,412 · cited 1×
“Deep learning (DL), a subtype of machine learning method, has been found to be satisfying in extracting information from high dimension image [6].”
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539 · cited 1×
“CD40L is a member of the TNF receptor superfamily, regulating immune response through CD40-expressing T cells activation [33].”
GOATOOLS: A Python library for Gene Ontology analyses
Klopfenstein, D. V., Zhang, L., Pedersen, B. S., Ramírez, F., Warwick Vesztrocy, A., Naldi, A., Mungall, C. J., Yunes, J. M., Botvinnik, O., Weigel, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28948-z · Cited by 1,290 · cited 1×
“Gene ontology (GO) function and pathway enrichment analyses were carried out with the python goa-tools package [25] and kobas 3.0 interface [26], respectively.”
InfluentialHead and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
Marur, S., & Forastiere, A. A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.12.017 · Cited by 1,174
Deep learning-based multi-omics integration robustly predicts survival in liver cancer
Chaudhary, K., Poirion, O. B., Lu, L., & Garmire, L. X. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0853 · Cited by 1,091 · cited 4×
“Furthermore, DL computation framework implemented by autoencoder has been used to predict survival in liver cancer by integrating multi-omics data including RNA sequencing, miRNA sequencing and methylation data, and, as a result, identifies two survival subtypes [9].”
Influentialsurvcomp: an R/Bioconductor package for performance assessment and comparison of survival models
Schröder, M. S., Culhane, A. C., Quackenbush, J., & Haibe-Kains, B. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr511 · Cited by 470 · cited 1×
“C-index was computed using concordance.index function in R survcomp package [21].”
A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION
DANAEE, P., GHAEINI, R., & HENDRIX, D. A. (2017) · Biocomputing 2017 · doi:10.1142/9789813207813_0022 · Cited by 291
Wichmann, G., Rosolowski, M., Krohn, K., Kreuz, M., Boehm, A., Reiche, A., Scharrer, U., Halama, D., Bertolini, J., Bauer, U., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29649 · Cited by 281 · cited 1×
“Confirmation set 3 (microarray gene expression): A total of 270 HNSCC samples with survival information were selected from E-GEOD-65858 [13] Illumina high-throughput HumanHT-12 V4.”
A Feature Selection Newton Method for Support Vector Machine Classification
Fung, G. M., & Mangasarian, O. L. (2004) · Computational Optimization and Applications · doi:10.1023/b:coap.0000026884.66338.df · Cited by 280 · cited 1×
“The penalizedSVM package [17, 18] (https://cran.r-project.org/web/packages/penalized SVM/index.html) was applied to conduct grid search to identify the optimal hyperparameters of the SVM model(s) using 5-fold CV.”
Gene selection using support vector machines with non-convex penalty
Zhang, H. H., Ahn, J., Lin, X., & Park, C. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti736 · Cited by 268
Schlesinger, M., & Bendas, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.28927 · Cited by 230 · cited 1×
“VCAM1 acts as a cell adhesion molecule and is relevant to tumor growth, metastasis and angiogenesis [38].”
B‐cell receptor signalling and its crosstalk with other pathways in normal and malignant cells
Seda, V., & Mraz, M. (2015) · European Journal of Haematology · doi:10.1111/ejh.12427 · Cited by 205 · cited 1×
“CD79A protein, namely B-cell antigen receptor complex-associated protein alpha chain, binds to CD79b to form a dimer related to membrane-bound immunoglobulin in B cells and is involved in B cell development and function [34].”
The role of claudins in cancer metastasis
Tabariès, S., & Siegel, P. M. (2017) · Oncogene · doi:10.1038/onc.2016.289 · Cited by 195
Gene Expression Profiling Predicts the Development of Oral Cancer
Saintigny, P., Zhang, L., Fan, Y.-H., El‐Naggar, A. K., Papadimitrakopoulou, V. A., Feng, L., Lee, J. J., Kim, E. S., Hong, W. K., & Mao, L. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0155 · Cited by 162 · cited 1×
“…set 1 (microarray gene expression): A total of 86 oral cancer samples with survival and recurrence information were gained from E-GEOD-26549 [11] Affymetrix high-throughput GeneChip Human Gene 1.0 microarray dataset (https://www.ebi.ac. uk/rrayexpress/arrays/A-AFFY-141/?ref=E-GEOD-26 549).”
InfluentialDNA methylation predicts recurrence from resected stage III proximal colon cancer
Ahn, J. B., Chung, W. B., Maeda, O., Shin, S. J., Kim, H. S., Chung, H. C., Kim, N. K., & Issa, J. J. (2011) · Cancer · doi:10.1002/cncr.25737 · Cited by 154 · cited 1×
“Accumulative genomic alterations play a critical role in HNSCC progression [27].”
TAN, J., UNG, M., CHENG, C., & GREENE, C. S. (2014) · Biocomputing 2015 · doi:10.1142/9789814644730_0014 · Cited by 147 · cited 1×
“It has been proved to be a promising DL method for extracting meaningful features from gene expression data of breast cancer [8].”
Moy, J. D., Moskovitz, J. M., & Ferris, R. L. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.035 · Cited by 113 · cited 1×
“Immunother-apy has been increasingly recognized as a promising novel therapy against HNSCC, calling for intense investigation into the biological mechanisms on immune process [32].”
Claudins in cancer: bench to bedside
Osanai, M., Takasawa, A., Murata, M., & Sawada, N. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1877-7 · Cited by 108 · cited 1×
“Emerging studies have established that deregulated claudins lead to disrupted tight junctions, thus contributing to cancer development and progression [35,36].”
Economopoulou, P., Perisanidis, C., Giotakis, E. I., & Psyrri, A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.34 · Cited by 103 · cited 1×
“The present study will provide a new idea for the effective clinical treatment of HNSCC.HNSCC has been regarded as an immune-suppressive disease characterized by profound immune defects [31].”
Xiao, Y., Wu, J., Lin, Z., & Zhao, X. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.10.004 · Cited by 101 · cited 1×
“More recently, it has been reported that autoencoder-based model is efficient and accurate in predicting lung cancer, stomach cancer and breast cancer using RNA-seq data [30].”
PEDLA: predicting enhancers with a deep learning-based algorithmic framework
Liu, F., Li, H., Ren, C., Bo, X., & Shu, W. (2016) · Scientific Reports · doi:10.1038/srep28517 · Cited by 101 · cited 1×
“An autoencoder is an hourglass-shaped unsupervised artificial neural network frequently used for classifi-cation [7].”
Chen, L., Cai, C., Chen, V., & Lu, X. (2016) · BMC Bioinformatics · doi:10.1186/s12859-015-0852-1 · Cited by 98 · cited 1×
“There is evidence for the utility of autoencoder to unveil the organization of transcriptomic machinery [28].”
Identification and Validation of a Multigene Predictor of Recurrence in Primary Laryngeal Cancer
Fountzilas, E., Kotoula, V., Angouridakis, N., Karasmanis, I., Wirtz, R. M., Eleftheraki, A. G., Veltrup, E., Markou, K. D., Nikolaou, A. C., Pectasides, D. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070429 · Cited by 75 · cited 1×
“Confirmation set 2 (microarray gene expression): Total 109 samples of primary laryngeal cancer with survival and recurrence information from E-GEOD-27020 [12] Affymetrix high-throughput GeneChip HG-U133A microarray dataset were applied in this study.”
Ching, T., Song, M.-A., Tiirikainen, M., Molnar, J., Berry, M., Towner, D., & Garmire, L. X. (2014) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gau046 · Cited by 68 · cited 1×
“For methylation data, beta values were transformed into M values by lumi package [24] (http://www.biocon ductor.org/packages/release/bioc/html/lumi.html) in R software.”
NbClust package: finding the relevant number of clusters in a dataset
Charrad, M., Ghazzali, N., Boiteau, V., & Niknafs, A. (2012) · HAL · Cited by 53
Ribeiro, I. P., Caramelo, F. J., Esteves, L., Menoita, J., Marques, F., Barroso, L., Miguéis, J., Melo, J. B., & Carreira, I. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14377-x · Cited by 48 · cited 1×
“In a recent study, a genomic predictive model has been developed for recurrence and metastasis development in HNSCC patients by a three-class support vector machine (SVM) algorithms [10].”
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach
Zhang, X., Li, Y., Akinyemiju, T., Ojesina, A. I., Buckhaults, P., Liu, N., Xu, B., & Yi, N. (2017) · Genetics · doi:10.1534/genetics.116.189191 · Cited by 41 · cited 1×
“Brier score is used to evaluate the mean difference between the observed and the predicted survival after a certain time in survival analysis [22].”
Self-citationIntegrating genomics in head and neck cancer treatment: Promises and pitfalls
Thariat, J., Vignot, S., Lapierre, A., Falk, A. T., Guigay, J., Obberghen‐Schilling, E. V., & Milano, G. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.03.005 · Cited by 41 · cited 1×
“Despite treatment advancements, the prognosis is dismal with an overall five-year survival rate of 50%, which is largely attributed to recurrence and metastasis [3].”
The Prognostic Role of Claudins in Head and Neck Squamous Cell Carcinomas
Nelhűbel, G. A., Károly, B., Szabó, B. M., Lotz, G., Kiss, A., Tóvári, J., & Kenessey, I. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9665-6 · Cited by 18 · cited 1×
“It has been found that polarity and distribution of claudins are altered in HNSCC and that expression of claudins associate with survival of patients [37].”
Physiology, pathophysiology, and clinical impact of claudins
Bleich, M., & Günzel, D. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1918-2 · Cited by 10
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Research works printed but not linked: 1
- Steck, 2008, On ranking in survival analysis: Bounds on the concordance index, Advances in Neural Information Processing Systems, 1209
Cited by
Multimodal deep learning for biomedical data fusion: a review
Stahlschmidt, S. R., Ulfenborg, B., & Synnergren, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab569 · Cited by 766
Tama, B. A., Kim, D. H., Kim, G., Kim, S. W., & Lee, S. (2020) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2020.00654 · Cited by 82
“3% [92] RNA sequencing, miRNA sequencing, methylation data HNSCC progress prediction Autoencoder and SVM 2×5-CV 360 Samples from TCGA C-index: 0.”
MethodEnhancing head and neck tumor management with artificial intelligence: Integration and perspectives
Zhong, N., Wang, H., Huang, X., Li, Z., Cao, L., Huo, F., Liu, B., & Bu, L. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.07.002 · Cited by 87
Zhao, J. Y., Zhao, B., Song, X., Lyu, C., Chen, W., Xiong, Y., & Wei, D. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad025 · Cited by 61
Elmakaty, I., Elmarasi, M., Amarah, A., Abdo, R., & Malki, M. I. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103777 · Cited by 54
Metadata
- Authors
- Zhao, Z., Li, Y., Wu, Y., & Chen, R.
- Affiliations
- Nanjing First Hospital (CN)
- Corresponding author
- Chen, Rongrong
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2019-12-30
- Volume
- 27
- Issue
- 1
- Pages
- 19-28
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- PMC
- PMC12662277
- OpenAlex
- W2982219485
- Cited by
- 23
- References
- 40
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 8 · 2021: 5 · 2020: 1
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Cancer Biomarkers (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- head and neck squamous cell carcinoma, disease progression prediction, prognostic model, multi-omics integration, RNA sequencing, miRNA sequencing, DNA methylation, autoencoder, progression-free survival, patient subgroups, differentially expressed genes, immune pathways, adhesion molecules, B cell receptor signaling, leukocyte transendothelial migration, personalized treatment
- MeSH terms
- Squamous Cell Carcinoma of Head and Neck, Deep Learning, Progression-Free Survival, RNA-Seq, Female, Humans, Male, Middle Aged, Prognosis, RNA, Messenger, Biomarkers, Tumor, Signal Transduction, Cell Adhesion Molecules, Gene Expression Regulation, Neoplastic, Disease Progression, Computational Biology, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.